SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $822,689 | -6.7% | 29,840 | +1.7% | 0.46% | -2.3% |
| Q2 2023 | $881,960 | -20.8% | 29,340 | -4.6% | 0.47% | -23.1% |
| Q1 2023 | $1,113,710 | +1.6% | 30,740 | 0.0% | 0.62% | -1.3% |
| Q4 2022 | $1,096,496 | +5.1% | 30,740 | -0.3% | 0.62% | -6.7% |
| Q3 2022 | $1,043,000 | +10.7% | 30,840 | -5.4% | 0.67% | +16.4% |
| Q2 2022 | $942,000 | -11.9% | 32,590 | -1.5% | 0.57% | -0.2% |
| Q1 2022 | $1,069,000 | +14.3% | 33,090 | +3.1% | 0.58% | +30.1% |
| Q4 2021 | $935,000 | – | 32,090 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |